SLC5A2 and diabetes mellitus: One important class of diabetes drugs is Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors, which inhibit the simultaneous reabsorption of glucose and sodium in the proximal tubules of the kidneys, leading to urinary glucose excretion.